New oral anticoagulants-TURKey (NOAC-TURK): Multicenter cross-sectional study

Altay S., Yildirimturk O., Cakmak H. A., Askin L., Sinan U. Y., BEŞLİ F., ...Daha Fazla

ANATOLIAN JOURNAL OF CARDIOLOGY, cilt.17, sa.5, ss.353-361, 2017 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 17 Sayı: 5
  • Basım Tarihi: 2017
  • Doi Numarası: 10.14744/anatoljcardiol.2016.7472
  • Dergi Adı: ANATOLIAN JOURNAL OF CARDIOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.353-361
  • Anahtar Kelimeler: new oral anticoagulants, atrial fibrillation, embolic complication, bleeding, ATRIAL-FIBRILLATION, STROKE INCIDENCE, CASE-FATALITY, RISK-FACTORS, MORTALITY, WARFARIN, THROMBOEMBOLISM, TRENDS
  • Recep Tayyip Erdoğan Üniversitesi Adresli: Evet

Özet

Objective: New oral anticoagulants (NOACs) are increasingly used both for prevention of stroke in non-valvular atrial fibrillation (NVAF) and the treatment of venous thromboembolism (VTE). In this study, we aimed to evaluate the current patterns of NOACs treatment in Turkey. Moreover, demographic and clinical parameters and bleeding and/or embolic events under NOACs treatment were analyzed.